Projected Earnings Date: 2025-05-22    (Delayed quote data   2025-06-30)
Last
 46.99
Change
 ⇑ +0.01   (+0.02%)
Volume
  4,867,858
Open
 46.99
High
 47.01
Low
 46.98
8EMA (Daily)
 46.95
40EMA (Daily)
 46.32
50EMA (Daily)
 46.12
STO (Daily)
 86.793
MACD Hist (Daily)
 -0.084
8EMA (Weekly)
 46.540
40EMA (Weekly)
 43.51
50EMA (Weekly)
 42.73
STO (Weekly)
 77.187
MACD Hist (Weekly)
 -0.079
SpringWorks Therapeutics Inc is a United States-based biopharmaceutical company. It is focused on identifying, developing, and commercializing therapies for underserved patient populations suffering from severe rare diseases and cancer. The firm's pipeline product includes Mirdametinib, Nirogacestat, and others.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com